EVALUATION OF ANTIMALARIAL-DRUGS IN A REGION WITH HIGH PREVALENCE OF CHLOROQUINE-RESISTANT PLASMODIUM-FALCIPARUM (BURUNDI, CENTRAL-AFRICA)
- 1 January 1985
- journal article
- research article
- Vol. 65, 115-121
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- In Vitro Antimalarial Activity of Tetrahydrofolate Dehydrogenase Inhibitors *The American Journal of Tropical Medicine and Hygiene, 1984
- EFFECTIVENESS OF AMODIAQUINE AS TREATMENT FOR CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM INFECTIONS IN KENYAThe Lancet, 1984
- EPIDEMIOLOGY OF MALARIA IN THE RUZIZI VALLEY, BURUNDI1984
- Evaluation of Amodiaquine Treatment of Chloroquine-Resistant Plasmodium Falciparum Malaria on Zanzibar, 1982The American Journal of Tropical Medicine and Hygiene, 1983
- Combined Chloroquine/Fansidar®-Resistant Falciparum Malaria Appears in East AfricaThe American Journal of Tropical Medicine and Hygiene, 1983
- SUSCEPTIBILITY OF PLASMODIUM FALCIPARUM TO PYRIMETHAMINE AND SULFADOXINE/PYRIMETHAMINE IN KISUMU, KENYAThe Lancet, 1982
- PYRIMETHAMINE SENSITIVITY IN PLASMODIUM-FALCIPARUM - DETERMINATION INVITRO BY A MODIFIED 48-HOUR TEST1980
- The Influence of Acetylator Phenotype on the Response to Sulfalene in Individuals with Chloroquine-Resistant Falciparum Malaria *The American Journal of Tropical Medicine and Hygiene, 1978
- DRUG SENSITIVITY OF PLASMODIUM FALCIPARUMThe Lancet, 1978
- Host Failure in Treatment of Malaria with Sulfalene and PyrimethamineAnnals of Internal Medicine, 1975